Ceta sterile compounding - Study guides, Class notes & Summaries

CETA EXAM PREP All questions and Answers 2024 100% SUCCESS RATED A+ Compounding Aseptic Containment Isolator (CACI) - ANS -Used for Compounding HD Drugs. -Class 1 CSP's may be placed in a SCA. -Class 2 CSP's cleanroom with ISO 7 Buffer Room. Compounding Aseptic Isolator (CAI) - ANS - Used for Compounding Sterile Non-HD Drugs. -Class 1 CSP's may be placed in a SCA. -Class 2 CSP's cleanroom with ISO 7 Buffer Room. Laminar Airflow Workbench (LAFW) - ANS - Limited to Non-Ster...

CETA QUESTIONS WITH VERIFIED ANSWERS Servicing Hazardous Drug Compounding Primary Engineering Controls - ANSWER CAG-005-2007 Compounding Isolator Testing Guide - ANSWER CAG-002-2006 Secondaring Engineering Controls - Matrix for Sterile Compounding Facilities - ANSWER CAG-008-2010 USP 797 Viable Environmental Sampling & Gowning Evaluation - ANSWER CAG-009-00 U.S. Department of Health and Human Services - ANSWER Guidance for Industry - Sterile Drug Products Produced by Aseptic Proce...

CETA TEST VERIFIED 100% CAG-002-2006 - ANSWER Compounding Isolator Testing Guide CAG-005-2007 - ANSWER Servicing Hazardous Drug Compounding Primary Engineering Controls CAG-008-2010 - ANSWER Secondaring Engineering Controls - Matrix for Sterile Compounding Facilities CAG-009-00 - ANSWER USP 797 Viable Environmental Sampling & Gowning Evaluation Guidance for Industry - Sterile Drug Products Produced by Aseptic Processing : Current Good Manufacturing Process - ANSWER U.S. Department...

CETA Study Guide Exam Questions With Answers All Correct Servicing Hazardous Drug Compounding Primary Engineering Controls - ANSWERCAG-005-2007 Compounding Isolator Testing Guide - ANSWER- CAG-002-2006 Secondaring Engineering Controls - Matrix for Sterile Compounding Facilities - ANSWER- CAG-008-2010 USP 797 Viable Environmental Sampling & Gowning Evaluation - ANSWER- CAG-009- 00 U.S. Department of Health and Human Services - ANSWER- Guidance for Industry - Sterile Drug Products Produ...

CETA Study Guide Exam Questions With Answers CAG-002-2006 - ANSWER- Compounding Isolator Testing Guide CAG-005-2007 - ANSWER- Servicing Hazardous Drug Compounding Primary Engineering Controls CAG-008-2010 - ANSWER- Secondaring Engineering Controls - Matrix for Sterile Compounding Facilities CAG-009-00 - ANSWER- USP 797 Viable Environmental Sampling & Gowning Evaluation Guidance for Industry - Sterile Drug Products Produced by Aseptic Processing : Current Good Manufacturing Process...

CETA Study Guide Exam Questions With Answers CAG-002-2006 - ANSWER- Compounding Isolator Testing Guide CAG-005-2007 - ANSWER- Servicing Hazardous Drug Compounding Primary Engineering Controls CAG-008-2010 - ANSWER- Secondaring Engineering Controls - Matrix for Sterile Compounding Facilities CAG-009-00 - ANSWER- USP 797 Viable Environmental Sampling & Gowning Evaluation Guidance for Industry - Sterile Drug Products Produced by Aseptic Processing : Current Good Manufacturing Process ...

CETA QUESTIONS WITH VERIFIED ANSWERS Servicing Hazardous Drug Compounding Primary Engineering Controls - ANSWER CAG-005-2007 Compounding Isolator Testing Guide - ANSWER CAG-002-2006 Secondaring Engineering Controls - Matrix for Sterile Compounding Facilities - ANSWER CAG-008-2010 USP 797 Viable Environmental Sampling & Gowning Evaluation - ANSWER CAG-009-00 U.S. Department of Health and Human Services - ANSWER Guidance for Industry - Sterile Drug Products Produced by Aseptic Proce...

CETA – All COMBINED LATEST UPDATE Critical Area - ANSWER An ISO Class 5 environment Critical Site - ANSWER A location that includes any component or fluid pathway surfaces (e.g., vial septa, injection ports, beakers) or openings (e.g., opened ampules, needle hubs) exposed and at risk of direct contact with air (e.g., ambient room or HEPA filtered), moisture (e.g., oral and mucosal secretions), or touch contamination. Risk of microbial particulate contamination of the critical si...

CETA – All COMBINED LATEST UPDATE Critical Area - ANSWER An ISO Class 5 environment Critical Site - ANSWER A location that includes any component or fluid pathway surfaces (e.g., vial septa, injection ports, beakers) or openings (e.g., opened ampules, needle hubs) exposed and at risk of direct contact with air (e.g., ambient room or HEPA filtered), moisture (e.g., oral and mucosal secretions), or touch contamination. Risk of microbial particulate contamination of the critical si...

CETA Study Guide Exam Questions With Answers All Correct Servicing Hazardous Drug Compounding Primary Engineering Controls - ANSWER- CAG-005-2007 Compounding Isolator Testing Guide - ANSWER- CAG-002-2006 Secondaring Engineering Controls - Matrix for Sterile Compounding Facilities - ANSWER- CAG-008-2010 USP 797 Viable Environmental Sampling & Gowning Evaluation - ANSWER- CAG-009-00 U.S. Department of Health and Human Services - ANSWER- Guidance for Industry - Sterile Drug Products ...